Methylcobalamin, one of the two active forms of vitamin B12, is the most effective analog in permeation and in transportation of neurons in subcellular organelles. Formulations of methylcobalamin are only commercially available in a few countries, which make them inaccessible for most patients. Extemporaneously prepared injections become the only option for those patients. The objective of this work is to study the physical and chemical (ultrahigh- performance liquid chromatography stability-indicating method) stabilities of methylcobalamin injections in the presence and absence of preservative during 181 days (considering the stability limit as 90% of initial concentration of methylcobalamin). The light exposure stability of injections in amber serum vials or clear syringes, solution in amber or clear glassware under typical pharmacy, clinical, and laboratory settings are also presented. Methylcobalamin injections, regardless of the concentrations and inactive ingredients, remained stable for at least 181 days at room temperature when stored in amber serum vials and protected from light. These experimental data suggested that the methylcobalamin injection solutions should be protected from light completely and light exposure in pharmacy, clinical, and laboratory setting should be minimized.

Download full-text PDF

Source

Publication Analysis

Top Keywords

methylcobalamin injections
12
light exposure
12
extemporaneously prepared
8
injections presence
8
presence absence
8
absence preservative
8
181 days
8
amber serum
8
serum vials
8
pharmacy clinical
8

Similar Publications

Rationale: The occurrence of delayed Horner's syndrome caused by a dog bite to the neck is rarely reported. Acute stress disorder (ASD) can easily be neglected when diagnosing this disease in trauma patients who cannot be effectively observed. The symptoms of Horner's syndrome may not be readily detected in patients with ASD.

View Article and Find Full Text PDF

High-altitude retinopathy and retinal hemorrhage: A case report.

Medicine (Baltimore)

November 2024

Department of Ophthalmology, Xuanwu Hospital, Capital Medical University, Beijing, China.

Article Synopsis
  • High-altitude retinopathy (HAR) is a vision-threatening condition caused by low oxygen levels at high altitudes, which may sometimes resolve on its own without symptoms.
  • A 41-year-old man experienced vision loss after rapidly ascending to high altitude, leading to diagnoses of HAR following thorough ophthalmic evaluations revealing serious eye issues.
  • Treatment included injections and medications to enhance eye health, and after 4 months, he showed improvement, emphasizing the importance of leaving high altitudes promptly to prevent long-term vision damage.
View Article and Find Full Text PDF

Context: Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus. Chinese patent medicines (CPMs) are widely used in clinical practice to treat DPN.

Objective: This study aims to summarize the latest evidence on the harms and benefits of CPMs as adjunctive therapy for DPN.

View Article and Find Full Text PDF

Chronic inflammatory demyelinating polyneuropathy (CIDP) during pregnancy presents diagnostic and management challenges. We report a case of a primigravida in her 30s, exhibiting progressive quadriparesis starting in the second trimester. Initially, her symptoms of weakness, numbness and progressive quadriparesis were attributed to vitamin B12 deficiency, leading to the administration of intramuscular methylcobalamin injection.

View Article and Find Full Text PDF

Pharmacokinetic profiles of methylcobalamin in rats after multiple administration routes by a simple LC-MS/MS assay with a small volume of plasma.

J Pharmacol Toxicol Methods

September 2024

Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd, Tokodai 5-1-3, Tsukuba-shi, Ibaraki 300-2635, Japan; Laboratory of Genomics-based Drug Discovery, Faculty of Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki 305-8575, Japan. Electronic address:

Methylcobalamin (MBL) is a vitamin B12 coenzyme and is effective for treating peripheral neuropathies. Little is known about pharmacokinetics (PK) of MBL in animals, we have developed a simple assay for MBL by using only 0.01 mL of plasma for PK of MBL in rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!